Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
1975
Rationale for reliability incl. deficiencies:
other: No data on ethical approval. Only 25 volunteers were tested, the concentration of the substance applied was not reported, no data on rest period
Cross-referenceopen allclose all
Reason / purpose for cross-reference:
reference to same study
Reason / purpose for cross-reference:
reference to other study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1975
Report date:
1975

Materials and methods

Type of sensitisation studied:
skin
Study type:
study with volunteers
Principles of method if other than guideline:
Maximisation test in humans
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Decan-4-olide
EC Number:
211-892-8
EC Name:
Decan-4-olide
Cas Number:
706-14-9
Molecular formula:
C10H18O2
IUPAC Name:
5-hexyloxolan-2-one
Constituent 2
Reference substance name:
5-hexyldihydrofuran-2(3H) -one
IUPAC Name:
5-hexyldihydrofuran-2(3H) -one
Details on test material:
- Name of test material (as cited in study report): #74-10-182 gamma-decalactone
- Physical state: no data
- Analytical purity: no data
- Impurities (identity and concentrations): no data
- Lot/batch No.: RIFM #74-10-182
- Expiration date of the lot/batch: no data
- Reception date: no data
- Stability under test conditions: no data
- Storage condition of test material: no data

Method

Type of population:
general
Ethical approval:
not specified
Subjects:
- Number of subjects exposed: 25
- Sex: 9 males and 16 female
- Age: 18-35 years
- Race: 16 whites, 9 blacks
- Demographic information: no data
Clinical history:
Heathly volunteer
Controls:
none
Route of administration:
dermal
Details on study design:
- Number of subjects exposed: 25
- Sex: 9 males and 16 female
- Age: 18-35 years
- Race: 16 whites, 9 blacks
- Demographic information: no data

Results and discussion

Results of examinations:
SYMPTOMS
- Frequency, level, duration of symptoms observed: none

NO. OF PERSONS WITH/OUT REACTIONS COMPARED TO STUDY POPULATION
- Number of subjects with positive reactions: 0
- Number of subjects with negative reactions: 25
- Number of subjects with equivocal reactions: 0
- Number of subjects with irritating reactions: 0

Any other information on results incl. tables

none

Applicant's summary and conclusion

Conclusions:
Under the conditions employed in this study, there was no evidence of sensitisation to γ-Decalactone.
Executive summary:

A panel of 25 male and female human healthy adult volunteers participated in a maximization test in which γ-Decalactone was applied to the volar forearm of the subjects under occlusive patches. During the induction phase patch were applied for five alternate-day 48 hour periods. The patches were removed 24 hours after application. As γ-Decalactone was not irritating in the pre-test, the patch site was pre-treated for 24 hours with 5 % aqueous sodium lauryl sulfate under occlusion. The challenge site was read on removal of the patch and 24 hours thereafter.

Under the conditions employed in this study, there was no evidence of sensitisation to γ-Decalactone.